|
|
 |
|
At
a Glance
|
|
Chairman and
CEO:
|
|
James
M. Cornelius
|
| Headquarters: |
|
345
Park Avenue
New York, New York, USA 10154-0037
212-546-4000
|
| Website
Address: |
|
www.bms.com
|
Stock
Exchange Listing:
|
|
BMY
(NYSE)
|
Number
of Employees:
|
|
41,000
|
| Global
Sales: |
|
$19.3
billion
|
| Patient
Assistance: |
|
During 2007, the Bristol-Myers Squibb Patient Assistance Foundation and company-sponsored programs under the LifeLines of Care initiative assisted more than 290,000 indigent patients in the U.S. in filling prescriptions with pharmaceuticals valued at more than $236 million at wholesale prices.
|
| Businesses:
|
|
Pharmaceuticals
Mead Johnson Nutritionals
|
| Selected
Key Products: |
|
Abilify®
(aripiprazole)
Atripla® (efavirenz
600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate
300 mg) Tablets
Avapro® (irbesartan) Tablets /
Avalide® (irbesartan-hydrochlorothiazide) Tablets
Baraclude®
(entecavir)
Coumadin® (Warfarin Sodium Tablets, USP) Crystalline
EMSAM® (selegiline
transdermal system)
Enfamil®
(infant formula)
Erbitux®
(Cetuximab)
IXEMPRA™ (ixabepilone) for injection
Orencia® (abatacept)
Plavix® (clopidogrel
bisulfate)
Pravachol®
(pravastatin sodium) Tablets
Reyataz® (atazanavir
sulfate)
Sprycel® (dasatinib) Tablets
Sustiva®
(efavirenz) |
Please
click on the product name to see Full Prescribing Information
including
boxed WARNINGS for Abilify®, Atripla®, Baraclude®, Coumadin®, EMSAM®, Erbitux® and IXEMPRA™,
including boxed WARNING for Avapro® / Avalide® regarding
use in pregnancy. As soon as pregnancy is detected, discontinue
use of Avapro® / Avalide®.
Data
above as reported in the Bristol-Myers Squibb 2007 Annual Report
|
[Top Page] [Search]
[Index] [Contact] [Home]
Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC.
Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.
© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy. |
|
|
|
|
|
